The latest immunotherapy news and developments
Mode-of-action of T-cell immunotherapies in focus
A new 3D imaging technique brings the working mode of T-cell immunotherapies into live view.…
Browsing: Immunotherapy
A diverse microbiome can protect against dangerous treatment complications
Kate Ann Markey, University of Washington One promising treatment for patients with blood cancers is…
Anti-rejection medication and immunotherapy kicks cancer and protects kidney transplants
Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant…
Whole exome sequencing predicts whether patients respond to cancer immunotherapy
Immunotherapies, such as immune checkpoint inhibitors, have transformed the treatment of advanced stage cancers. Unlike…
Study identifies T-cell populations that predict response to immunotherapy
Immune checkpoint blockade (ICB) therapy has shown promising potential for treating many types of cancer,…
A machine learning model to predict immunotherapy response in cancer patients
Immunotherapy is a new cancer treatment that activates the body’s immune system to fight against…
Black and hispanic patients less likely to receive lifesaving immunotherapy
Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving…
“Cellular Brake” offers clue to autoimmune response during immunotherapy
A “cellular brake”, which could prevent lung cancer patients from developing a dangerous autoimmune response…
Scientists prevent “exhaustion” in T cells
When faced with a formidable foe for months on end, the immune system’s T cells begin…
Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complication after COVID-19 vaccination
Does COVID-19 vaccination increase the risk of cancer patients undergoing therapy with immune checkpoint inhibitors…